• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    139.15 Down 3.13(2.20%) Feb 8, 4:00PM EST
    Prev Close:142.28
    Open:138.02
    Bid:135.65 x 100
    Ask:141.14 x 100
    1y Target Est:206.11
    Beta:1.59616
    Earnings Date:Apr 21 - Apr 25 (Est.)
    Day's Range:136.44 - 141.40
    52wk Range:130.51 - 208.88
    Volume:2,146,264
    Avg Vol (3m):1,605,250
    Market Cap:31.35B
    P/E (ttm):207.69
    EPS (ttm):0.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 2.20%31.35B
    AMGNDown 1.41%107.82B
    BAXDown 3.97%19.69B

    Key Statistics

    Forward P/E (1 yr):20.20
    P/S (ttm):12.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.21
    Quarterly EPS Est (Mar-16) :1.14
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.33

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback